CD21low B cells in systemic sclerosis: A possible marker of vascular complications
Authors:
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Clinical Immunology
- Vol. 213, 108364
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Expansion of Functionally Anergic CD21−/low Marginal Zone-like B Cell Clones in Hepatitis C Virus Infection-Related AutoimmunityThe Journal of Immunology, 2011
- Clonal B cells in patients with hepatitis C virus–associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subsetBlood, 2011
- Circulating CD21lowB cells in common variable immunodeficiency resemble tissue homing, innate-like B cellsProceedings of the National Academy of Sciences, 2009
- Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individualsJournal of Experimental Medicine, 2008
- The EUROclass trial: defining subgroups in common variable immunodeficiencyBlood, 2008
- Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement?Rheumatology, 2006
- General considerations for lung function testingEuropean Respiratory Journal, 2005
- Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosisMolecular Immunology, 2004
- A new CD21low B cell population in the peripheral blood of patients with SLEClinical Immunology, 2004
- Altered blood B lymphocyte homeostasis in systemic sclerosis: Expanded naive B cells and diminished but activated memory B cellsArthritis & Rheumatism, 2004